What causes an acute exacerbation of cystic fibrosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Acute Exacerbation of Cystic Fibrosis

Acute exacerbations of cystic fibrosis are primarily caused by respiratory infections, with Pseudomonas aeruginosa being the most common bacterial pathogen, followed by viral infections such as rhinovirus, and environmental factors that trigger increased inflammation in the airways. 1, 2

Bacterial Infections

Pseudomonas aeruginosa

  • Most common and significant bacterial pathogen in CF patients 1
  • Presence of P. aeruginosa in the airways, especially mucoid strains, causes:
    • Immediate and rapid reduction of lung function
    • Increased sputum volumes
    • Higher neutrophil numbers and inflammatory response
    • Progressive lung damage and respiratory failure if left untreated 1
  • Chronic P. aeruginosa infection leads to:
    • More frequent exacerbations
    • Faster decline in pulmonary function
    • Increased morbidity and mortality 1

Other Bacterial Pathogens

  • Staphylococcus aureus (including MRSA)
  • Klebsiella species
  • Haemophilus influenzae
  • Achromobacter xylosoxidans
  • Stenotrophomonas maltophilia 3

Viral Infections

Viral infections are increasingly recognized as significant triggers of CF exacerbations:

  • Present in up to 80% of exacerbations in children with CF 2

  • Most common viral pathogens:

    • Rhinovirus (43.4% of exacerbations) - most predominant
    • Bocavirus (20%)
    • Adenovirus (13.3%)
    • Enterovirus (10%)
    • Human metapneumovirus (6.7%)
    • Influenza viruses 2, 4
  • Viral-bacterial co-infections:

    • Significant relationship between influenza A, enterovirus, human metapneumovirus and bacterial infections 2
    • Viruses can facilitate bacterial colonization and worsen exacerbations 4
    • Non-mucoid P. aeruginosa with rhinovirus co-infection increases IL-1β production and compromises epithelial barrier function 5

Pathophysiological Mechanisms

Inflammation and Immune Response

  • Increased inflammation with higher neutrophil numbers and released serine proteinases 1
  • Altered cytokine production during infections:
    • Increased IL-1β during viral-bacterial co-infections
    • Protease-mediated degradation of IL-6 during non-mucoid P. aeruginosa and rhinovirus co-infection 5
  • Compromised epithelial barrier function during co-infections 5

Upper Respiratory Tract Involvement

  • Paranasal sinuses serve as a reservoir for bacteria and a site for bacterial adaptation 3
  • Infections can spread from sinuses to the lower respiratory tract 3

Clinical Presentation and Diagnosis

Signs and symptoms of an acute exacerbation include:

  • Increased cough and sputum production
  • Changes in sputum characteristics (color, consistency)
  • Decreased pulmonary function (FEV1)
  • Increased respiratory rate
  • Fever
  • Decreased appetite and weight loss 1

Diagnosis typically involves:

  • Clinical assessment
  • Pulmonary function testing
  • Sputum culture for bacterial pathogens
  • Nasal swabs with multiplex PCR for viral detection 2

Prevention and Management

  • Regular monitoring with monthly or at least quarterly microbiological cultures 6
  • Early treatment of P. aeruginosa colonization with combination therapy:
    • Inhaled antibiotics (colistin or tobramycin)
    • Oral ciprofloxacin 6
  • For acute exacerbations:
    • Combination antibiotic therapy directed against P. aeruginosa
    • Increased airway clearance therapy 1
    • Continuation of chronic therapies for maintenance of lung health 1

Important Considerations

  • The relationship between bacterial density reduction and improvement in lung function suggests that antibiotic therapy directly impacts clinical outcomes 1
  • CF patients with CFRD (CF-related diabetes) have a greater frequency and severity of pulmonary exacerbations 1
  • Proper nebulizer hygiene and technique are essential when using inhaled antibiotics 6
  • Monthly monitoring for P. aeruginosa in patients without previous colonization is recommended 6

Understanding these causes and mechanisms is crucial for early intervention and effective management of acute exacerbations in CF patients, ultimately improving long-term outcomes and quality of life.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Respiratory bacterial infections in cystic fibrosis.

Current opinion in pulmonary medicine, 2013

Research

Viruses in cystic fibrosis patients' airways.

Critical reviews in microbiology, 2017

Guideline

Treatment of Pseudomonas Aeruginosa Colonization

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.